Air Street Capital

Fern Labs strives to develop, experiment, and construct, ensuring that this new era of computers serves a higher purpose.

Sereact specializes in the development of artificial intelligence-based robotics aimed at enhancing warehouse automation. The company has created an adaptable AI system that facilitates robot-assisted picking of various items, specifically designed for applications in electronic retail and e-commerce. By utilizing their intelligent software tools, Sereact helps businesses automate their end processes, thereby increasing productivity and reducing operational costs. Their innovative approach addresses automation gaps, allowing clients to achieve greater cost-efficiency in their operations.

Odyssey operates as an AI start-up, provides hollywood-grade visual AI.

Profluent Bio is an artificial intelligence-driven protein design company focused on creating innovative proteins that overcome existing industry challenges. By integrating advanced generative AI models with real-world laboratory characterization, Profluent combines machine learning techniques to analyze and engineer biomolecules. This approach supports biotechnology research and development, aiming to enhance human health and facilitate various industrial applications.

Interloom Technologies redefines process automation for an AI future.

Intenseye Inc. is a technology company based in San Jose, California, founded in 2018, specializing in AI-powered video analytics for occupational health and safety. The platform enables enterprises to monitor their facilities continuously by utilizing existing cameras to conduct automated inspections without the need for additional hardware. Through advanced computer vision and machine learning, Intenseye's software analyzes real-time video feeds to identify safety violations, such as improper use of personal protective equipment and hazardous conditions. This capability allows health and safety teams to receive immediate notifications of potential risks, facilitating rapid response measures. Importantly, Intenseye's system is designed to protect worker privacy by not capturing personally identifiable information. The company aims to enhance workplace safety while providing clients with scalable and effective tools to mitigate accidents and improve overall operational safety.

CellVoyant Technologies Limited, founded in 2021, focuses on advancing biotechnology through an AI-first approach to stem cell-based therapies aimed at treating chronic diseases. The company employs AI-driven live cell imaging to predict and optimize stem cell differentiation, allowing for the scalable and precise manufacturing of various human cells and tissues. This innovative technology is rooted in research from the Carazo Salas lab at the University of Bristol, merging expertise in cell biology, computer vision, engineering, and machine learning. With a commitment to translating cutting-edge science into practical healthcare solutions, CellVoyant addresses significant challenges in medicine. The company, led by Founder and CEO Rafael Carazo, has garnered support from a network of investors experienced in AI and biotechnology. Currently generating $2.5 million in annual revenue, CellVoyant is positioned to make a substantial impact in the biotechnology sector through its transformative therapies.

Delian Alliance Industries is a seed-stage company focused on developing autonomous technology aimed at addressing national security challenges within the EU and its allies. By infusing the military industry with the innovative culture of venture-capital-funded startups, the company is creating a framework for future platforms dedicated to civil defense and protection. Delian Alliance Industries has developed an advanced autonomous surveillance system that utilizes artificial intelligence to enhance mission-critical applications, reconnaissance, and situational awareness. This system analyzes, fuses, and geolocates diverse sensor data in real-time, allowing defense and civil engineers to integrate information from various sources, such as cameras and radars, into a coherent operational view.

Sereact specializes in the development of artificial intelligence-based robotics aimed at enhancing warehouse automation. The company has created an adaptable AI system that facilitates robot-assisted picking of various items, specifically designed for applications in electronic retail and e-commerce. By utilizing their intelligent software tools, Sereact helps businesses automate their end processes, thereby increasing productivity and reducing operational costs. Their innovative approach addresses automation gaps, allowing clients to achieve greater cost-efficiency in their operations.

Poolside is an artificial intelligence platform that offers foundation concepts and infrastructure. It aims to unlock humanity's potential by pursuing AGI for software creation, with the fundamental belief that the transitional path for humanity to AGI is by building specific capabilities instead of a general-purpose approach. It also helps users utilize the power of software creation and understand future systems.

V7 Ltd is a company based in London, United Kingdom, that specializes in developing a platform for computer vision artificial intelligence. Founded in 2018, V7 provides tools for creating and managing high-quality annotated datasets, including images, videos, documents, and medical imaging files. The platform streamlines the annotation process through features like auto-labeling, quality assurance, and team collaboration, significantly reducing the time required for data preparation. V7's solutions are designed to integrate seamlessly with existing technology stacks, allowing users to manage their machine learning operations efficiently. By offering an open API and additional tools like the Darwin-py SDK and CLI, V7 empowers businesses to maintain control over their models, tasks, and datasets while enhancing the accuracy of their AI applications.

Hedera Dx is a healthcare venture based in Epalinges, Vaud, established on July 1, 2021, that develops a liquid biopsy solution aimed at simplifying tumor profiling for hospital labs. This technology provides clinicians with a streamlined experience for accessing information and conducting liquid biopsy tests, which are essential for early cancer detection, therapy selection, and monitoring recurrence. By addressing challenges such as IVD compliance, privacy infrastructure, and validation, Hedera Dx enhances the efficiency of existing software workflows while offering key capabilities that were previously lacking. The company's innovations provide medical professionals with new opportunities to reduce cancer mortality and healthcare costs.

Profluent Bio is an artificial intelligence-driven protein design company focused on creating innovative proteins that overcome existing industry challenges. By integrating advanced generative AI models with real-world laboratory characterization, Profluent combines machine learning techniques to analyze and engineer biomolecules. This approach supports biotechnology research and development, aiming to enhance human health and facilitate various industrial applications.

Anagenex is a seed stage biotechnology company focused on advancing drug discovery through its innovative platform. The company aims to tackle challenging pharmaceutical targets by utilizing a technology that combines machine learning with DNA-encoded libraries. This approach allows for the rapid analysis of compounds and the generation of extensive data sets, facilitating parallel biochemical experiments. By leveraging proprietary artificial intelligence models, Anagenex enables researchers to efficiently develop new small molecule drugs for medically significant applications.

Athenian is a software platform designed to assist engineering leaders in enhancing team alignment and performance with organizational objectives. By focusing on shared understanding rather than individual metrics, Athenian facilitates continuous improvement across teams, codebases, workflows, and processes. The platform quantifies bottlenecks, measures growth, and provides visibility into work, enabling users to identify key success indicators and productivity challenges. Athenian’s tools aim to optimize software delivery and improve business communications, ultimately fostering a culture of continuous improvement that can lead to increased profitability for its clients.

Gandeeva Therapeutics is a precision biotechnology company focused on developing innovative therapeutics by leveraging cryogenic electron microscopy and machine learning to target key protein-protein interactions. The company's structure-guided drug discovery platform includes target prediction and validation, hit identification through virtual and fragment library screening, and lead optimization. Gandeeva has established a strong preclinical oncology pipeline aimed at addressing challenging cancers with unique protein interaction modulators, including interfacial glues and allosteric inhibitors. Headquartered in the Greater Vancouver area, Canada, Gandeeva is dedicated to enhancing the drug discovery process and reducing the risk of late-stage clinical failures.

Anagenex is a seed stage biotechnology company focused on advancing drug discovery through its innovative platform. The company aims to tackle challenging pharmaceutical targets by utilizing a technology that combines machine learning with DNA-encoded libraries. This approach allows for the rapid analysis of compounds and the generation of extensive data sets, facilitating parallel biochemical experiments. By leveraging proprietary artificial intelligence models, Anagenex enables researchers to efficiently develop new small molecule drugs for medically significant applications.

InVivo AI, founded in 2017 and based in Montreal, Canada, specializes in utilizing artificial intelligence to enhance pharmaceutical research and development, particularly in the area of preclinical toxicology. The company aims to streamline the drug discovery process by implementing advanced AI methods for molecular representation and de novo design, which allows for the creation of novel chemical compounds that can address complex biological challenges. Through its innovative platform, InVivo AI is positioned to significantly improve the efficiency and effectiveness of drug design, paving the way for breakthroughs in pharmaceutical science.

Intenseye Inc. is a technology company based in San Jose, California, founded in 2018, specializing in AI-powered video analytics for occupational health and safety. The platform enables enterprises to monitor their facilities continuously by utilizing existing cameras to conduct automated inspections without the need for additional hardware. Through advanced computer vision and machine learning, Intenseye's software analyzes real-time video feeds to identify safety violations, such as improper use of personal protective equipment and hazardous conditions. This capability allows health and safety teams to receive immediate notifications of potential risks, facilitating rapid response measures. Importantly, Intenseye's system is designed to protect worker privacy by not capturing personally identifiable information. The company aims to enhance workplace safety while providing clients with scalable and effective tools to mitigate accidents and improve overall operational safety.

Modern Intelligence is a technology company founded in 2020 and based in San Jose, California, specializing in artificial intelligence solutions for the defense sector. The company leverages proprietary advancements in information and complexity theory to develop a unique AI system designed to enhance military operations. Its hierarchical approach significantly improves scalability compared to traditional neural networks, facilitating high accuracy in few-shot learning for new challenges and enabling the resolution of previously difficult problems. Additionally, Modern Intelligence has developed a maritime sensor platform that accelerates AI adoption within the defense industry. This platform empowers military hardware and command systems to effectively track, analyze, and learn about maritime targets during operations such as drug interdiction and fleet combat, thereby enhancing decision-making capabilities with minimal data input.

Gourmey is a cultivated meat company based in Paris, France, founded in 2019. It specializes in producing ethical foie gras derived from duck cells, offering a sustainable alternative to traditional methods that involve force-feeding and slaughter. By cultivating animal cells in a controlled laboratory environment, Gourmey creates meat products that prioritize health, environmental sustainability, and animal welfare. The company aims to provide delicious meat options for consumers who are conscious of their choices and seek innovative solutions in the food industry.

Intenseye Inc. is a technology company based in San Jose, California, founded in 2018, specializing in AI-powered video analytics for occupational health and safety. The platform enables enterprises to monitor their facilities continuously by utilizing existing cameras to conduct automated inspections without the need for additional hardware. Through advanced computer vision and machine learning, Intenseye's software analyzes real-time video feeds to identify safety violations, such as improper use of personal protective equipment and hazardous conditions. This capability allows health and safety teams to receive immediate notifications of potential risks, facilitating rapid response measures. Importantly, Intenseye's system is designed to protect worker privacy by not capturing personally identifiable information. The company aims to enhance workplace safety while providing clients with scalable and effective tools to mitigate accidents and improve overall operational safety.

V7 Ltd is a company based in London, United Kingdom, that specializes in developing a platform for computer vision artificial intelligence. Founded in 2018, V7 provides tools for creating and managing high-quality annotated datasets, including images, videos, documents, and medical imaging files. The platform streamlines the annotation process through features like auto-labeling, quality assurance, and team collaboration, significantly reducing the time required for data preparation. V7's solutions are designed to integrate seamlessly with existing technology stacks, allowing users to manage their machine learning operations efficiently. By offering an open API and additional tools like the Darwin-py SDK and CLI, V7 empowers businesses to maintain control over their models, tasks, and datasets while enhancing the accuracy of their AI applications.

Allcyte is a biotechnology start-up specializing in functional drug testing using primary human material. The company has developed a high-content imaging platform that analyzes drug action at a single-cell level, closely simulating in vivo conditions. This approach allows for precise evaluation of how cancer treatments may perform in real patients. By employing advanced image analysis and machine learning techniques, Allcyte generates actionable insights that assist physicians and pharmaceutical companies in prioritizing drug development efforts and treatment decisions. The company aims to facilitate personalized medicine for cancer patients, ensuring that the right therapies are matched to the right individuals.

LabGenius Ltd is a biopharmaceutical company based in London that focuses on discovering new biological molecules through the integration of artificial intelligence, automation, and synthetic DNA. Founded in 2012, the company has developed a robotic platform known as EVA, which acts as a robot scientist capable of designing, conducting, and learning from its own experiments. LabGenius specializes in developing next-generation protein therapeutics aimed at addressing unmet medical needs, including conditions like Inflammatory Bowel Disease. Their innovative approach utilizes advanced machine learning and synthetic biology to engineer the properties of protein drugs, enhancing attributes such as protease stability and tissue penetration. This technology enables the efficient creation of protein therapeutics, providing physicians with access to cutting-edge treatments developed through robotic automation.

Mission Barns, Inc., founded in 2018 and based in Berkeley, California, specializes in the production of cell-cultured meat derived from animal cells. The company employs cellular agriculture techniques to cultivate animal cells in a nutrient-rich environment, allowing for the sustainable growth of meat without the adverse effects associated with traditional intensive animal agriculture. By starting with a small number of cells from select animals, Mission Barns aims to provide consumers with juicy and savory meat products that meet the increasing demand for sustainable food alternatives. The company's innovative approach lies at the intersection of biotechnology and food science, contributing to a more responsible food system.

Vtrus specializes in the development of advanced robotics technology, focusing on the ABI (Autonomy Brain Implant), which is a modular unit designed to enhance robots' understanding of their environment. This system simplifies the complexities of perception, planning, and control by offering a straightforward message-passing interface, facilitating quicker implementation of robotics projects. In addition to the ABI, Vtrus also creates autonomous inspection drones that autonomously gather critical data for monitoring industrial facilities. These drones are equipped with an array of sensors, including cameras, thermal imagers, and three-dimensional scanners, enabling them to produce complementary 3D map scans along with geo-anchored multimedia content. This technology allows for more efficient post-inspection analysis, significantly improving data collection capabilities while minimizing the risks associated with accessing hazardous or hard-to-reach locations.

Mission Barns, Inc., founded in 2018 and based in Berkeley, California, specializes in the production of cell-cultured meat derived from animal cells. The company employs cellular agriculture techniques to cultivate animal cells in a nutrient-rich environment, allowing for the sustainable growth of meat without the adverse effects associated with traditional intensive animal agriculture. By starting with a small number of cells from select animals, Mission Barns aims to provide consumers with juicy and savory meat products that meet the increasing demand for sustainable food alternatives. The company's innovative approach lies at the intersection of biotechnology and food science, contributing to a more responsible food system.

Hedera Dx is a healthcare venture based in Epalinges, Vaud, established on July 1, 2021, that develops a liquid biopsy solution aimed at simplifying tumor profiling for hospital labs. This technology provides clinicians with a streamlined experience for accessing information and conducting liquid biopsy tests, which are essential for early cancer detection, therapy selection, and monitoring recurrence. By addressing challenges such as IVD compliance, privacy infrastructure, and validation, Hedera Dx enhances the efficiency of existing software workflows while offering key capabilities that were previously lacking. The company's innovations provide medical professionals with new opportunities to reduce cancer mortality and healthcare costs.